BRKR News | Roxom Stocks

1 BTC

- USD

Loading market data...

Mkt Cap

$8.35B

Volume

1.27M

Next Earnings

November 2nd

Mkt Cap

$8.61B

Volume

1.27M

Next Earnings

November 2nd

Chart Financials Earnings News About Dividends Insider Filings

Bruker Gains 66.3% in a Year: What's Driving the Rally?Bruker Corporation (BRKR) shares gained 66.3% over the past year, driven by strong demand in biopharma, diagnostics, and mass spectrometry. However, the company faces a $134.9M goodwill impairment, currency headwinds, and restructuring costs. Full-year 2026 revenue guidance was lowered to $3.54-$3.57B due to currency pressures, though the company maintains a solid financial position with $184.9M in cash.Zacks Investment Research · Oct 8, 2026

Are Options Traders Betting on a Big Move in Bruker Stock?Bruker Corporation (BRKR) is experiencing elevated implied volatility in its December 2026 $75 put options, suggesting traders expect significant price movement. However, the fundamental outlook remains weak, with analysts downgrading estimates over the past 60 days, pushing the consensus estimate down from 55 cents to 42 cents per share. The stock holds a Zacks Rank #3 (Hold) rating.Zacks Investment Research · Oct 5, 2026

Why Bruker (BRKR) is a Top Momentum Stock for the Long-TermBruker Corporation (BRKR), a life science and materials research systems manufacturer, is highlighted as a momentum investment opportunity despite holding a #3 (Hold) Zacks Rank. The stock has gained 4.3% over the past four weeks and features strong Momentum and VGM Style Scores of A and B respectively. One analyst raised earnings estimates for fiscal 2026, with the consensus estimate at $2.12 per share and an average earnings surprise of +22.7%.Zacks Investment Research · Oct 2, 2026

Automated Microscopy Market Advances as AI-Powered Image Analysis Transforms Digital Pathology and Semiconductor InspectionThe global Automated Microscopy Market is projected to reach USD 16.63 billion by 2035, growing at 7.35% CAGR, driven by AI-enabled image analysis, whole-slide digital pathology, and expanding applications in life sciences and semiconductor inspection. The U.S. market is expected to reach USD 5.19 billion by 2035 at 7.1% CAGR, while Asia Pacific is the fastest-growing region at 9.8% CAGR. Software is the fastest-growing segment, with electron microscopy emerging as the fastest-growing type.GlobeNewswire Inc. · Sep 23, 2026

Global Metabolomics Market to Reach US$9.01 Billion by 2035 as Precision Medicine, Biomarker Discovery and Advanced Analytics Unlock New OpportunitiesThe global metabolomics market is projected to grow from USD 2.81 billion in 2025 to USD 9.01 billion by 2035, expanding at a CAGR of 12.36%. Growth is driven by precision medicine, biomarker discovery, and multiomics adoption, with oncology accounting for over 44% of the market. However, Q1 2026 faced challenges from geopolitical tensions, supply chain disruptions, and elevated logistics costs affecting laboratory budgets and procurement timelines.GlobeNewswire Inc. · Sep 22, 2026

Mass Spectrometry Market Size Worth USD 14.09 Billion by 2035 | SNS InsiderThe global mass spectrometry market is valued at $6.68 billion in 2025 and is projected to reach $14.09 billion by 2035, growing at a CAGR of 7.74%. Growth is driven by pharmaceutical manufacturing, omics research, clinical diagnostics, and precision medicine adoption. North America leads the market while Asia Pacific records the fastest growth at 9.12% CAGR.GlobeNewswire Inc. · Jul 17, 2026

Spatial Genomics and Transcriptomics Market Size to Reach USD 1.90 Billion by 2035, Growing at a 12.23% CAGR | SNS InsiderThe global spatial genomics and transcriptomics market is projected to grow from USD 0.60 billion in 2025 to USD 1.90 billion by 2035 at a 12.23% CAGR. Growth is driven by increased adoption of AI-powered spatial biology technologies, precision medicine initiatives, and high-resolution molecular profiling in oncology and translational research. North America is expected to lead with 46% market share, while Asia Pacific shows the highest growth rate at 16.69% CAGR.GlobeNewswire Inc. · Jun 30, 2026

Omics-Based Clinical Trials Research Report 2026: $47.78 Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035FThe omics-based clinical trials market is experiencing robust growth, expanding from $31.71 billion in 2025 to $34.49 billion in 2026 with an 8.8% CAGR, and projected to reach $47.78 billion by 2030. Growth is driven by increasing demand for personalized medicine, genomics advancements, AI-enabled patient recruitment, and biomarker-driven trial designs. North America leads the market while Asia-Pacific shows rapid expansion potential.GlobeNewswire Inc. · Apr 24, 2026

Silver Jumps To $89 After Soft CPI, JPMorgan Falls 3%: What's Moving Markets Tuesday?Markets traded cautiously on Tuesday despite benign inflation data (CPI at 2.7% YoY, core CPI at 2.6%) that supported Fed rate cut expectations. Silver surged 4.5% to $89/oz amid supply concerns. Major indices remained flat with the S&P 500 near record highs. Earnings results were mixed: JPMorgan fell 3% on weak investment banking fees, Delta slid 4% on soft guidance, while Moderna rallied 14% on bullish forecasts. Intel and AMD gained on analyst upgrades. Energy stocks outperformed as crude rose 2.7% to $61/barrel.Benzinga · Jan 13, 2026

Why This Investment Advisor Sold Off Its $3.6 Million Bruker StakeLane Generational, a Massachusetts-based investment advisor, completely sold its $3.6 million stake in Bruker during Q3 2025, exiting all 87,607 shares amid the company's challenging market performance.The Motley Fool · Nov 4, 2025

BRKRBruker Corporation

BRKR

Pay with—

Start Trading

Available Balance0.00

Your PositionYou don't own any BRKR yet.

Related Tickers

Earnings

Dividends

Last · Sep 21Quarterly

Amount$0.0500

Yield0.36%

Annual$0.20

Mkt Cap

$8.35B

Volume

1.27M

Next Earnings

November 2nd